NCT04970901 2026-03-13A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)ADC Therapeutics S.A.Phase 1 Recruiting200 enrolled